DocuSign's third-quarter fiscal 2026 performance presented a paradox that left Wall Street scratching its heads. The company delivered solid earnings results that exceeded forecasts, yet investors responded by punishing the stock, which dropped 4.9% following the December 4 earnings announcement. Th

Background: How Social Security's Retirement Age Has Been Shifting
The Social Security system has undergone a series of automatic adjustments that weren't the result of new legislation, but rather were built into the program decades ago. One particular modification has affected millions of

The FTSE 100 showed minimal movement, closing around 9,838 points amidst mixed economic signals, with improved consumer confidence contrasting with weak retail sales. Select stocks supported the market, while improved government borrowing indicated fiscal stability.

Ryman Healthcare Ltd. reported a significant loss of NZ$49.65 million in the first half of the year, a sharp decline from last year's profit of NZ$58.99 million. Despite revenue growth to NZ$413.78 million, operational challenges impacted profitability. Market response was cautiously optimistic, with shares rising 2.1%.

Arcus Biosciences and Gilead Sciences have terminated the Phase 3 STAR-221 trial due to ineffective results compared to chemotherapy alternatives. Instead, Arcus will focus on developing casdatifan and expanding its pipeline in inflammatory and autoimmune diseases, supported by a strong cash position.

Fighting Back in Search
When ChatGPT first launched, it shook the tech world—suddenly, Google Search faced real competition. But Alphabet didn't stay on the sidelines for long. The company shot back with AI Overviews and AI Mode, turning its search engine into an AI-powered platform. The

Apple is challenging India's new antitrust regulations in court, which allow the Competition Commission to impose penalties based on global revenue, potentially costing Apple $38 billion. The company argues this standard is disproportionate and inequitable, contesting investigations into its market conduct.

Benjamin Graham's value investing framework continues to resonate with modern investors seeking stocks trading below intrinsic value. This analysis examines five healthcare stocks through the lens of Graham's proven methodology, which emphasizes low valuation multiples, strong balance sheets, and

Coinbase Global, Inc. (COIN) outperformed the market with a 2.47% gain, but saw a 30-day increase of only 0.44%, lagging behind sector averages. Analysts predict a decline in quarterly earnings but potential annual growth. COIN's valuation reflects investor expectations despite market volatility.

Zoom Communications (ZM) dropped 2.8% recently but gained 5.26% over the past month. Upcoming earnings on November 24, 2025, are expected to show year-over-year growth. ZM trades at a discount compared to its sector, reflecting cautious analyst sentiment.

You've probably heard traders talk about "stocks" without thinking twice about what type they mean. That's because common stock dominates the conversation -- it makes up the major indexes, drives most IPOs, and is what 99% of retail investors actually own. But there's another class of equity

Taiwan Semiconductor Manufacturing Company (TSMC) is navigating a critical balance: expanding production capacity globally while protecting one of the industry's most impressive profitability metrics. The chipmaker has embarked on an ambitious international buildout, establishing new fabrication fac

The Redomiciliation Milestone
Neuphoria Therapeutics has finalized a transformative corporate restructuring that positions Bionomics Limited—previously domiciled in Australia—under its parent company umbrella in the United States. As of December 23, 2024 (New York time), the arrangement took

We've all been there: after months of watching a stock bleed red, suddenly there's a green day. Then another. The price climbs to levels you haven't seen in forever. Your finger hovers over the sell button. But is this real recovery, or just a trap?
The Dead Cat Bounce Explained: Why

The Current State of Dogecoin
Dogecoin has faced significant headwinds in 2025, with a decline of approximately 62% year-to-date. Currently trading at $0.13, DOGE sits roughly 82% below its all-time high of $0.73 reached in May 2021. Despite the hype surrounding Elon Musk and the newly formed

As speculation mounts about potential economic slowdown through 2026, the investment landscape is shifting. Economic momentum, once robust, has begun to cool noticeably. Household balance sheets show caution, borrowing costs remain sticky, and corporate capital allocation has tightened

As investors prepare strategies for the coming year, many wonder whether January truly delivers market gains—or if this seasonal trend has become outdated. The January effect has long been a talking point among traders and financial analysts, suggesting that equity markets tend to outperform

Retrocession represents a significant but often overlooked aspect of investment management that directly affects your investment returns. At its core, this practice involves financial institutions sharing portions of their collected fees with intermediaries—such as financial advisors and

The IRS has raised IRA contribution limits for 2024, providing an opportunity for greater retirement savings. Understanding these changes and income thresholds can help optimize your savings strategy. Early contributions enhance wealth growth through compounding.

The Strategic Play Behind Netflix House
Netflix just launched Netflix House Philadelphia, marking a significant shift toward physical retail experiences. The company is doubling down on this strategy with Dallas next month and a Las Vegas location slated for 2027. But is this a legitimate